Targeting Integrin-Linked Kinase in Drug-Resistant Ovarian Cancer

 

vasas1Dr. Pablo E. Vivas-Mejia is an assistant professor in the Cancer Center and the Department of Biochemistry of the University of Puerto Rico Medical Sciences Campus. Dr. Vivas-Mejia’s research interest areas are to understand the mechanisms by which ovarian cancer cells become resistant to chemotherapy and to design and test siRNA and miRNA-based therapies for advanced cancers that are resistant to current standard chemotherapy regimens. Dr. Vivas-Mejia’s ultimate goal is to establish an Ovarian Cancer Research Program in Puerto Rico encompassing basic science, translational research, and training of future cancer researchers from minority institutions.